Clinical Trials · NCT05225974
A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- The Affiliated Hospital of Qingdao University
- Enrollment
- 32
- Start date
- Jul 2021
- Locations
- 1 site, China
- Primary endpoint
- Peak Plasma Concentration (Cmax)